Welcome to Nordic Society of Gynaecological Oncology

ENGOT-EN1/FANDANGO

 

Study documentation (link to documents is only accessible with password to www.nsgo.org). 

Click HERE for access.  

 

Study sponsor

NSGO

NSGO Project Manager

Mette Engell

NSGO, Rigshospitalet, Copenhagen, Denmark

mette.engell@regionh.dk

+45 3545 3398

Study Chair

Mansoor Raza Mirza
NSGO, Rigshospitalet, Copenhagen, Denmark

mansoor.raza.mirza@regionh.dk

+45 3545 3939

Drug

Nintedanib

Phase

II

Randomized trial

Yes

Type

Double-blinded

Total number of patients

148 patients required 

Number of patients recruited

Recruitment statistics – link

Trial status

Recruitment closed

Date of first site activated

16.11.2016

eCRF

Open Clinica test  link (protected information – access only with login)

Open Clinica Live  link (protected information – access only with login)

Site list

Site list addes soon (protected information – access only with login)

Protocol summary

ClinicalTrials.gov – link

Click HERE for access.